Eun Wie Cho

Title: Eun Wie Cho: Innovator in Cancer Treatment

Introduction

Eun Wie Cho is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of cancer research through her innovative work on antibodies. Her research focuses on developing novel therapeutic options for cancer treatment.

Latest Patents

Eun Wie Cho holds a patent for an "Anti-TM4SF4 antibody and uses thereof." This invention relates to antibodies or antigen-binding fragments that specifically bind to TransMembrane 4 Superfamily Member 4 (TM4SF4). These antibodies exhibit proliferation inhibitory activity against cancer cells, effectively preventing or treating cancer. Additionally, they reduce the self-renewal ability of cancer stem cells, making them useful in treating cancers with poor prognoses in conventional anticancer treatments. She has 1 patent to her name.

Career Highlights

Eun Wie Cho is affiliated with the Korea Atomic Energy Research Institute, where she conducts her research. Her work has garnered attention for its potential impact on cancer therapies and has positioned her as a key figure in the scientific community.

Collaborations

Eun Wie Cho collaborates with notable colleagues, including In Gyu Kim and Rae Kwon Kim. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

Eun Wie Cho's innovative work in developing anti-TM4SF4 antibodies represents a significant advancement in cancer treatment. Her contributions to the field highlight the importance of research in finding effective therapies for challenging medical conditions.